SN

Sagar Nareshbhai Talaviya

Active Director Director DIN 11265857
DIN 11265857 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sagar Nareshbhai Talaviya

Data last updated:

Sagar Nareshbhai Talaviya is a Director at Aeterna Chemtech Private Limited (since 2025). The company operates in Pharma.

DIN 11265857
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aeterna Chemtech Private Limited U20110GJ2025PTC166837
Director28 Aug 20252025Active

Board colleagues of Sagar Nareshbhai Talaviya

NameDINCompanyDesignation
Ankit Ghanshyambhai Khunt11265858Aeterna Chemtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aeterna Chemtech Private Limited
Premium access

Shareholding and investment profile for Sagar Nareshbhai Talaviya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sagar Nareshbhai Talaviya

Sagar Nareshbhai Talaviya currently holds 1 directorship: Aeterna Chemtech Private Limited (Director, since 28 Aug 2025).

Sagar Nareshbhai Talaviya was first appointed on 28 Aug 2025 as Director at Aeterna Chemtech Private Limited.

The current boards of Sagar Nareshbhai Talaviya's companies include Ankit Ghanshyambhai Khunt (Aeterna Chemtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available